| 序号 | 证券代码 | 证券简称 | 区间涨跌幅 | 年化波动率 | | | --- | --- | --- | --- | --- | --- | | | | | [×向首日] 2025-1-1 [×同居日] 2025-9-11 [单位] %↓ | [記始交易日期] 2025-1-1 [截止交易日期] 2025-9-11 [周期] 周 | | | | | | | [收益率量法] 普通收益率 | | | | | | | [单位] % | | | 1 | 970070.CNI | 创业板人工智能 | 86.2631 | | 42.1999 | | 2 | 931071.CSI | 人工智能 | 76.8025 | | 39.2216 | | 3 | 930713.CSI | CS人工智 | 60.5312 | | 35.3267 | | ব | 950180.CSI | 科创AI | 55.0197 | | 36.1793 | 12日早盘，昨日暴涨的AI产业链回调蓄势，创业板人工智能指数跌逾1%。光模块龙头普遍下跌，天孚 通信领跌5%，新易盛、中际旭创跌超2%。但算力租赁、云计算方向独立活跃，易华录盘中大涨 ...

| | 代码 | 名称 | 现价 | | | | --- | --- | --- | --- | --- | --- | | | 9626 | 哔哩哔哩-W | 206 6 | | 6.49% | | 25 | 9988 | 阿里巴巴-W | 151.90 | 8 600 | | | 3 | 3896 | 金山云 | 8.950 | 0 35 | 407% | | 4 | 1357 | 美图公司 | 9 530 | 0.365 | 3.98% | | 5 | 0020 | 商汤-W | | | 2.84% | | 6 | 3888 | 金山软件 | 35,000 | 0.980 | 2.88% | | 7 | 0700 | 腾讯控股 | 647.000 | 17.500 | | | 8 | 2556 | 迈富时 | 55.150 | 1 350 | 251% | | 0 | 0268 | 全蝶国际 | | | | | 10 | 1024 | 快手-W | 75.000 | 1 650 | 2.25% | 港股AI核心工具——港股互联网ETF（513770）场内价格一度涨逾2%，现涨1．78%，盘中再探历史新 ...

化工板块今日（9月12日）又陷回调，反映化工板块整体走势的化工ETF（516020）开盘后迅速下探， 盘中场内价格一度跌超1%，截至发稿，跌0.8%。 成份股方面，锂电、氟化工、氮肥等板块部分个股跌幅居前。截至发稿，恩捷股份大跌超4%，多氟多 跌超3%，鲁西化工、新宙邦、联泓新科等多股跌超2%，拖累板块走势。 值得注意的是，尽管今日出现回调，但"反内卷"行情以来，化工板块表现仍显著优于大盘。数据显示， 截至昨日（9月11日）收盘，自7月初以来，化工ETF（516020）标的指数细分化工指数累计涨幅已达到 23.55%，显著优于同期上证指数（12.51%）、沪深300指数（15.55%）等A股主要指数。 中国银河证券表示，供给端，近几年化工行业资本开支及在建产能增速趋于放缓，但预计存量产能及在 建产能仍需时间消化。需求端，下半年随政策刺激效果逐渐显现、终端产业回暖动能逐步转强，内需潜 力有望充分释放。看好下半年化工品的结构性机会及行业估值修复空间。 如何把握化工板块反弹机遇？借道化工ETF（516020）布局效率或更高。公开资料显示，化工ETF （516020）跟踪中证细分化工产业主题指数，全面覆盖化工各个细分 ...

Core Viewpoint - The A+H innovative drug sector is experiencing a rebound, with significant gains in both A-share and Hong Kong-listed ETFs focused on innovative drugs, indicating strong market confidence despite recent negative news from the U.S. regarding potential restrictions on Chinese pharmaceuticals [1][3]. Market Performance - The Hong Kong innovative drug ETF (520880) has seen a net subscription of over 160 million yuan in a single day, continuing a streak of eight consecutive days of inflows totaling nearly 350 million yuan [3]. - Major players in the Hong Kong innovative drug sector, such as BeiGene and CanSino Biologics, have reported gains exceeding 4%, while smaller companies like Jiateng Biopharma-B have surged over 17% to reach a historical high [1][3]. Industry Trends - The fund manager of the Hong Kong innovative drug ETF (520880) expressed confidence that U.S. restrictions on Chinese innovative drugs are unlikely to be implemented, citing that multinational corporations (MNCs) have already procured over 90 billion USD worth of Chinese innovative drug patents from January to August this year [3][4]. - The ETF has undergone a "purification" adjustment, completely removing CXO companies and focusing solely on innovative drug R&D firms, which is expected to enhance its performance in the sector [4]. Investment Insights - The recent market volatility may present a buying opportunity for high-quality innovative drug stocks, as the ETF is positioned to capitalize on potential rebounds in the sector [4]. - The Hong Kong innovative drug ETF (520880) has achieved a year-to-date increase of 119.75%, outperforming other indices in the same category prior to the recent adjustments [4][5].

Core Viewpoint - The domestic AI industry is experiencing significant growth, driven by strong policy support, technological advancements, and surging market demand, particularly highlighted by the performance of the domestic AI-focused ETF and its constituent stocks [1][4][5]. Group 1: Market Performance - The domestic AI-focused ETF (589520) saw an intraday price increase of nearly 3%, currently up 1.81%, marking a three-day consecutive rise [1]. - Key constituent stocks such as Chipone Technology surged over 15%, while Cambricon and Yuke Tech rose by more than 4% and 3% respectively [1]. - The ETF's trading threshold was reduced from approximately 120 yuan to about 60 yuan following a 1:2 share split, making it more accessible for investors [5]. Group 2: Industry Trends - Major global tech companies, including Oracle, Microsoft, Google, and Meta, are significantly increasing their capital expenditures on AI infrastructure, indicating a robust demand for high-end chips and related hardware [3]. - The Chinese government's policies are strongly supporting the integration of AI across key sectors, with initiatives like the "Artificial Intelligence+" action plan aiming for deep integration by 2027 [4]. Group 3: Technological Advancements - Domestic companies are making rapid technological breakthroughs, with Huawei and Alibaba Cloud demonstrating advancements in large-scale computing capabilities [4]. - The processing capacity in China has dramatically increased, with daily token processing volume soaring from 100 billion to 30 trillion within a year and a half [4]. Group 4: Investment Opportunities - The ETF is positioned to benefit from the ongoing domestic AI industry growth, with a focus on companies that are well-placed in the AI supply chain [6][7]. - The ETF's top ten holdings account for over 71.66% of its weight, with semiconductors being the largest sector, representing over 54.1% [7].

Core Viewpoint - Chinese assets have experienced a significant surge, with the Nasdaq Golden Dragon China Index rising nearly 3% and Alibaba's US stock increasing by 8% [1] Market Performance - The US Labor Department reported that the Consumer Price Index (CPI) for August rose by 2.9% year-on-year, while the core CPI increased by 3.1%, both in line with expectations [1] - The Hang Seng Index opened 1.74% higher on September 12, with the Hang Seng Tech Index rising by 1.97% [1] - Notable gains were seen in major Chinese stocks, including Alibaba-W leading with a 6% increase, Tencent Holdings and Kuaishou-W both rising nearly 3%, and Xiaomi Group-W up over 1% [1] Foreign Investment Trends - Foreign investors net bought a total of $39 billion in Chinese bonds and stocks in August, indicating increased foreign capital allocation to Chinese assets [2] - Global hedge funds recorded the highest net buying of Chinese stocks since September 2024 [2] Sector Analysis - The Hong Kong tech sector is viewed as undervalued globally, with high-growth and high-volatility stocks expected to benefit from increased foreign investment [3] - The Hong Kong Internet ETF (513770) has seen a continuous inflow of funds, with a net inflow of 2.792 billion yuan over the past 20 days [4] ETF Performance - The Hong Kong Internet ETF (513770) has outperformed the Hang Seng Tech Index by over 10 percentage points in terms of cumulative returns this year [8] - The ETF's latest scale has surpassed 10 billion yuan, achieving a historical high, with an average daily trading volume of nearly 600 million yuan [10] Top Holdings - The top four holdings in the Hong Kong Internet ETF include Xiaomi Group-W, Tencent Holdings, Alibaba-W, and Meituan-W, collectively accounting for 54.74% of the fund [6]

登录新浪财经APP 搜索【信披】查看更多考评等级 专题：北京公募基金高质量发展系列活动 新时代、新基金、新价值 2023年中国证监会发布了《公募基金行业费率改革工作方案》，该方案对公募基金费率上限进行规定， 推动基金产品管理费率、托管费率大幅降低，行业正式进入公募基金降费"三步走"的第一阶段。2024年 监管发布的《公开募集证券投资基金证券交易费用管理规定》对公募基金的股票佣金费率进行了规定， 降低了对投资者的"隐形"收费。在此基础之上，2025年中国证监会重磅发布了《推动公募基金高质量发 展行动方案》（以下简称《行动方案》），基金管理费将从"固定收费"逐步成为与业绩比较基准挂钩的 浮动费率。《行动方案》不仅保护了投资者的利益，也激励了基金管理人不断提升其投资管理能力，有 助于形成投资者与管理人真正实现利益共享和风险共担的新价值。 对于投资者而言，与考虑哪只产品更加"便宜"相比，未来或更应该关注基金产品业绩比较基准的设定是 否合理，基金经理的投资策略是否出现"风格漂移"，基金经理能否长期创造超额收益。除此以外，投资 者应科学建立资产配置方案，并将其与所选择基金产品的策略进行匹配。从选择合适的方案到再到选择 合 ...

专题：北京公募基金高质量发展系列活动 新时代、新基金、新价值 在贯彻落实《推动公募基金高质量发展行动方案》的大背景下，由北京证监局指导，北京证券业协会携 手北京公募基金管理人、基金销售机构、基金评价机构及多家主流媒体，共同启动"新时代·新基金·新价 值——北京公募基金高质量发展在行动"主题活动。此次系列活动将围绕公幕基金高质量发展核心主 题，结合行业政策解读、投资者教育、产品创新实践、风险管理经验等方向，开展多种形式的宣传宣 讲。 赎回费调整被认为是对行业影响较大的新规内容之一，涉及基金管理人、销售机构及机构投资者等多 方。债券型基金取消了"持有7天免赎回费"的设定，且整体赎回费率有所提高，而"持有6个月免赎回 费"的设定，也将对短债基金、债券指数基金影响较大。投资者角度来看，偏好短债产品的个人投资者 可能因成本变化调整投资行为，这将影响销售机构短债产品的销售模式，机构投资者同样需应对费率调 整带来的投资适配问题。不过，此项调整也能进一步引导市场树立长期投资理念，帮助基金产品稳定负 债端，助力投资业绩提升。值得注意的是，ETF、同业存单基金、货币基金等产品可豁免上述规则，这 意味着原短债产品的投资者或会转向这 ...

专题：北京公募基金高质量发展系列活动 新时代、新基金、新价值 MACD金叉信号形成，这些股涨势不错！ 责任编辑：石秀珍 SF183 作为资本市场的重要参与者，银华基金深刻把握政策导向，在金融"五篇大文章"对应的重点领域全面布 局，深耕普惠金融，以专业能力回应国家战略与社会发展所需。 一是提升投研内驱力。截止2024年底，银华基金已服务持有人逾7300万，累计分红超1000亿元；二是积 极让利投资者。响应监管号召，银华基金积极推动1700亿元产品降费，并开展浮动费率试点，强化客户 与管理人之间的利益共振；三是做好投资者陪伴服务，助力投资者"坚持做长期正确的事"。 普之于众，惠之于民。展望未来，银华基金还将继续为促进全体人民共同富裕持续贡献金融力 量，"普"写"惠"民新篇章！ 近日，在北京证监局指导下，北京证券业协会携手北京四十余家公募基金管理人、基金销售机构、基金 评价机构以及多家主流媒体，共同启动"北京公募基金高质量发展系列活动"。本次活动以"新时代·新基 金·新价值"为主题，旨在强化投资者教育与保护，推动公募基金行业转型升级，提升服务实体经济能 力，打造北京金融高质量发展新名片。 当前，我国公募基金行业正步 ...

专题：北京公募基金高质量发展系列活动 新时代、新基金、新价值 近日，为贯彻落实《推动公募基金高质量发展行动方案》，在北京证监局指导下，北京证券业协会携手 北京公募基金管理人、基金销售机构等多方启动"北京公募基金高质量发展系列活动"，以"新时代・新 基金・新价值——北京公募基金高质量发展在行动"为主题，聚焦普惠金融推进与投资者教育保护。作 为参与机构，中邮基金紧扣"投资者利益绑定"理念，依托固收+产品特性与精细化陪伴服务，为不同生 命周期投资者提供适配方案。 一、固收+产品：匹配全生命周期需求的核心载体 不同人生阶段的投资者，风险偏好与资金需求差异显著，中邮基金基于此，通过固收+产品特性分化实 现精准适配。 考核聚焦三大维度：一是投资者留存率，重点关注持有3年以上客户占比，引导团队重视长期体验；二 是投教转化效果，要求投研人员每年参与多场沟通活动，投教内容覆盖产品逻辑与风险提示，并通过问 卷验证投资者理解程度；三是投资者满意度，从信息及时性、内容易懂性等维度评分，未达标团队需优 化流程。 青年积累期（25-35岁）投资者收入增长但储蓄有限，既需资金稳健，又要资金灵活，低波动型固收+产 品正契合这一需求：以纯债为 ...